IRIS
Perna, Giampaolo Robert
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.680
AS - Asia 5.271
EU - Europa 2.266
SA - Sud America 2.125
AF - Africa 306
Continente sconosciuto - Info sul continente non disponibili 299
OC - Oceania 14
Totale 17.961
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.428
SG - Singapore 2.673
BR - Brasile 1.723
CN - Cina 958
VN - Vietnam 895
IT - Italia 738
FI - Finlandia 362
IE - Irlanda 266
DE - Germania 186
NG - Nigeria 174
AR - Argentina 159
FR - Francia 156
CA - Canada 133
NL - Olanda 129
GB - Regno Unito 122
IN - India 94
HK - Hong Kong 91
TR - Turchia 83
ID - Indonesia 82
BD - Bangladesh 77
EC - Ecuador 74
RU - Federazione Russa 64
MX - Messico 58
CO - Colombia 56
IQ - Iraq 55
SE - Svezia 47
ZA - Sudafrica 44
IL - Israele 37
IR - Iran 36
PY - Paraguay 35
ES - Italia 32
CZ - Repubblica Ceca 26
MA - Marocco 24
PK - Pakistan 24
UA - Ucraina 24
KR - Corea 23
PL - Polonia 23
CL - Cile 22
SA - Arabia Saudita 20
PE - Perù 19
VE - Venezuela 19
EG - Egitto 17
UY - Uruguay 14
AT - Austria 13
JM - Giamaica 13
MY - Malesia 13
TW - Taiwan 13
AU - Australia 12
BE - Belgio 12
CR - Costa Rica 11
JP - Giappone 11
KE - Kenya 11
UZ - Uzbekistan 11
AE - Emirati Arabi Uniti 10
NP - Nepal 9
PT - Portogallo 9
TN - Tunisia 9
HN - Honduras 8
CH - Svizzera 7
DZ - Algeria 7
AL - Albania 6
ET - Etiopia 6
LB - Libano 6
RO - Romania 6
AZ - Azerbaigian 5
JO - Giordania 5
LT - Lituania 5
PA - Panama 5
PH - Filippine 5
SN - Senegal 5
TH - Thailandia 5
BO - Bolivia 4
BY - Bielorussia 4
GA - Gabon 4
GE - Georgia 4
GR - Grecia 4
KZ - Kazakistan 4
NI - Nicaragua 4
OM - Oman 4
RS - Serbia 4
TT - Trinidad e Tobago 4
AM - Armenia 3
BB - Barbados 3
BH - Bahrain 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
EU - Europa 3
GT - Guatemala 3
HR - Croazia 3
HU - Ungheria 3
KG - Kirghizistan 3
BA - Bosnia-Erzegovina 2
BW - Botswana 2
EE - Estonia 2
KH - Cambogia 2
KW - Kuwait 2
MD - Moldavia 2
MK - Macedonia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
Totale 17.648
Salva come PNG Salva come JPEG
Città #
Wilmington 1.142
Singapore 1.051
The Dalles 494
San Mateo 437
Shanghai 429
Ashburn 406
Chandler 406
Helsinki 362
Ho Chi Minh City 309
Dallas 287
Milan 272
Dublin 264
Ann Arbor 252
Council Bluffs 252
Leawood 237
Princeton 236
Beijing 230
Lawrence 225
San Jose 209
Hanoi 206
Benin City 173
Fairfield 158
New York 145
São Paulo 144
Woodbridge 138
Rome 120
Paris 118
Santa Clara 110
Los Angeles 92
Amsterdam 91
Hong Kong 83
Boardman 80
London 64
Toronto 63
Kocaeli 57
Rio de Janeiro 49
Buffalo 44
Da Nang 41
Bradenton 40
Naples 40
Brasília 39
Orem 38
Belo Horizonte 33
Phoenix 33
Guayaquil 31
Haiphong 31
Curitiba 29
Porto Alegre 29
Seattle 29
Turin 29
Norwalk 27
Mansfield 24
Newark 24
Figino 21
Asunción 20
Campinas 20
Chicago 20
Falkenstein 20
Chennai 19
Munich 19
Oakland 19
Fortaleza 18
Hải Dương 18
Monmouth Junction 18
Quito 18
Baghdad 17
Charlotte 17
Thái Nguyên 17
Brno 16
Goiânia 16
Montreal 16
Ha Long 15
Ribeirão Preto 15
Salvador 15
Atlanta 14
Brooklyn 14
Cape Town 14
Jakarta 14
Johannesburg 14
Lima 14
Philadelphia 14
Recife 14
Warsaw 14
Biên Hòa 13
Bogotá 13
Bắc Ninh 13
Corbin 13
Guarulhos 13
Moscow 13
Ninh Bình 13
Riyadh 13
Seoul 13
Boston 12
Ellicott City 12
Frankfurt am Main 12
Hortolândia 12
Houston 12
Pune 12
Abbiategrasso 11
Bauru 11
Totale 10.663
Salva come PNG Salva come JPEG
Nome #
A Clinically-Translatable Machine Learning Algorithm for the Prediction of Alzheimer's Disease Conversion in Individuals with Mild and Premild Cognitive Impairment 172
A Novel Ensemble-Based Machine Learning Algorithm to Predict the Conversion From Mild Cognitive Impairment to Alzheimer's Disease Using Socio-Demographic Characteristics, Clinical Information, and Neuropsychological Measures 164
A comparison of citalopram and paroxetine in the treatment of panic disorder: A randomized, single-blind study 152
Baseline respiratory parameters in panic disorder: A meta-analysis 150
Antianxiety medications for the treatment of complex agoraphobia: pharmacological interventions for a behavioral condition 149
Are Anxiety Disorders Associated with Accelerated Aging? A Focus on Neuroprogression 148
A segregation study of panic disorder in families of panic patients responsive to the 35% CO2 challenge 140
Carbon dioxide-induced panic attacks and quantitative electroencephalogram in panic disorder patients 138
Are Respiratory Abnormalities Specific for Panic Disorder? A Meta-Analysis 138
A clinically-translatable machine learning algorithm for the prediction of Alzheimer's disease conversion: further evidence of its accuracy via a transfer learning approach 137
Approximate entropy of respiratory patterns in panic disorder 131
BALANCE REHABILITATION WITH PERIPHERAL VISUAL STIMULI IN NON-RESPONDER PATIENTS WITH PANIC DISORDER AND AGORAPHOBIA: A PILOT STUDY 130
Are there advances in pharmacotherapy for panic disorder? A systematic review of the past five years 128
'Precision' or 'personalized' psychiatry: different terms - same content? 127
Anxiety sensitivity and 35% CO2 reactivity in patients with panic disorder 121
Antipanic drug modulation of 35% CO2 hyperreactivity and short-term treatment outcome 119
The Panic Respiration Connection 115
Heart rate variability: Can it serve as a marker of mental health resilience?: Special Section on "Translational and Neuroscience Studies in Affective Disorders" Section Editor, Maria Nobile MD, PhD 115
Acoustic startle response in panic disorder 112
35-PERCENT CO2 CHALLENGE IN PANIC AND MOOD DISORDERS 112
Alexithymia, resilience, somatic sensations and their relationships with suicide ideation in drug naive patients with first-episode major depression: An exploratory study in the "real world" everyday clinical practice 111
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part II: OCD and PTSD 110
Childhood adversities in patients with fibromyalgia: are they related to comorbid lifetime major depression? 110
The 35% CO2 hyperreactivity and clinical symptomatology in patients with panic disorder after week of treatment with citalopram: An open study 110
A comprehensive review on the efficacy of S-adenosyl-L-Methionine in major depressive disorder 109
Respiration in children at risk for panic disorder 107
ALEXITHYMIA AND ITS RELATIONSHIPS WITH ACUTE PHASE PROTEINS AND CYTOKINE RELEASE: AN UPDATED REVIEW 106
Alexithymia, suicidal ideation, and serum lipid levels among drug-naive outpatients with obsessive-compulsive disorder 105
Alexithymia and Suicide Risk in Psychiatric Disorders: A Mini-Review 105
A Case Study of the 35% CO2 Challenge 104
AGE AT ONSET OF PANIC DISORDER - INFLUENCE OF FAMILIAL LIABILITY TO THE DISEASE AND OF CHILDHOOD SEPARATION ANXIETY DISORDER 104
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part I: Anxiety disorders 101
Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a "real-world" chart review study 100
The 35% CO2 challenge test in patients with social phobia 98
Alexithymia, responsibility attitudes and suicide ideation among outpatients with obsessive-compulsive disorder: An exploratory study 97
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3 96
A long-term prospective evaluation of first-degree relatives of panic patients who underwent the 35% CO2 challenge 96
Agomelatine beyond Borders: Current Evidences of Its Efficacy in Disorders Other than Major Depression 96
COVID-19 and panic disorder: clinical considerations for the most physical of mental disorders 94
Psicopatologia Funzionale 94
Toward a personalized therapy for panic disorder: preliminary considerations from a work in progress 93
S-Adenosyl-L-Methionine Augmentation in Patients with Stage II Treatment-Resistant Major Depressive Disorder: An Open Label, Fixed Dose, Single-Blind Study 92
Is There Room for Second-Generation Antipsychotics in the Pharmacotherapy of Panic Disorder? A Systematic Review Based on PRISMA Guidelines 91
Childhood Trauma, Temperament, and Character in Subjects With Major Depressive Disorder and Bipolar Disorder 90
Personality biomarkers of pathological gambling: A machine learning study 90
CO2-induced panic attacks: A twin study 88
Modelos explicativos de los trastornos de angustia: una perspectiva integradora 86
ALPHA(2)-ADRENERGIC RECEPTOR SENSITIVITY IN PANIC DISORDER .1. GH RESPONSE TO GHRH AND CLONIDINE STIMULATION IN PANIC DISORDER 86
Il Disturbo di Panico in Infanzia 84
ALPHA(2)-ADRENERGIC RECEPTOR SENSITIVITY IN PANIC DISORDER .2. CORTISOL RESPONSE TO CLONIDINE STIMULATION IN PANIC DISORDER 83
Effect of agomelatine treatment on C-reactive protein levels in patients with major depressive disorder: an exploratory study in "real-world," everyday clinical practice 82
Panic disorder: from respiration to the homeostatic brain 82
Pharmacologic effect of imipramine, paroxetine, and sertraline on 35% carbon dioxide hypersensitivity in panic patients: A double-blind, random, placebo-controlled study 82
Is there a link between child abuse and neglect ans anxiety disorders? 82
Neuroimaging in Generalized Anxiety Disorder 81
The Novel Antipsychotic Cariprazine (RGH-188): State-of-the-Art in the Treatment of Psychiatric Disorders 81
Panic disorder: the role of the balance system 81
Clonazepam in the treatment of psychiatric disorders: an update 80
Family history of panic disorder and hypersensitivity to CO2 in patients with panic disorder 80
Reduced cortical thickness and increased gyrification in generalized anxiety disorder: a 3 T MRI study 80
The revolution of personalized psychiatry: will technology make it happen sooner? 80
An update of safety of clinically used atypical antipsychotics 80
I Disturbi D’Ansia 80
Human-Induced Pluripotent Stem Cell Technology: Toward the Future of Personalized Psychiatry 78
Neuroprogression in anxiety disorders 78
Language of dyspnea in panic disorder 78
The role of spatial store and executive strategy in spatial working memory: a comparison between patients with obsessive-compulsive disorder and controls 78
Smoking and respiratory irregularity in panic disorder 78
Cigarette smoking has no pro-cognitive effect in subjects with obsessive-compulsive disorder: A preliminary study 78
Anxiety sensitivity in children of panic disorder patients 78
Features of mood associated with high body weight in females with fibromyalgia 77
Emerging drugs for panic disorder 77
Current and Future Perspectives on the Major Depressive Disorder: Focus on the New Multimodal Antidepressant Vortioxetine 76
The FDA "Black Box" Warning on Antidepressant Suicide Risk in Young Adults: More Harm Than Benefits? 76
Common genetic, clinical; demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders 76
Novel investigational therapeutics for panic disorder 76
Long-Term Pharmacological Treatments of Anxiety Disorders: An Updated Systematic Review 76
Is there a role for pharmacogenetics in the treatment of panic disorder? 75
Short-Term Psychiatric Rehabilitation in Major Depressive and Bipolar Disorders: Neuropsychological-Psychosocial Outcomes 75
Biomarker-Guided Tailored Therapy in Major Depression 74
Basi Biologiche e Inquadramento Clinico e Terapeutico dei Disturbi d’Ansia 74
C-REACTIVE PROTEIN LEVEL AND ITS RELATIONSHIP WITH SUICIDE RISK AND ALEXITHYMIA AMONG NEWLY DIAGNOSED, DRUG-NAIVE PATIENTS WITH NON-AFFECTIVE PSYCHOSIS 74
Alexithymia, Suicide Ideation, C-Reactive Protein, and Serum Lipid Levels Among Outpatients with Generalized Anxiety Disorder 74
Self-reported quality of life and clinician-rated functioning in mood and anxiety disorders: Relationships and neuropsychological correlates 74
Cardiorespiratory response to physical exercise and psychological variables in panic disorder 74
Temperament, Character and Anxiety Sensitivity in Panic Disorder: A High-Risk Study 74
Nosografia 74
La paura, il panico e l’ansia 73
Terapia Farmacologica della Fobia Sociale 73
Antipanic efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene 73
Comparison of the treatment with paroxetine and reboxetine in panic disorder: a randomized, single-blind study 73
La rabbia e l’aggressività 72
Mediation effect of recent loss events on weight gain in obese people who experienced childhood parental death or separation 72
Farmacoterapia del disturbo di panico 71
Is there cardiac risk in panic disorder? An updated systematic review 71
Growth hormone response to growth hormone-releasing hormone stimulation in obsessive-compulsive disorder 71
Emozioni e Neuroscienze 71
Dizziness, migrainous vertigo and psychiatric disorders 71
Cariprazine (RGH-188): a new pharmacological target option for the treatment of schizophrenia, bipolar disorders and depression? 71
Cardiorespiratory Assessments in Panic Disorder Facilitated by Wearable Devices: A Systematic Review and Brief Comparison of the Wearable Zephyr BioPatch with the Quark-b2 Stationary Testing System 70
Totale 9.439
Salva come PNG Salva come JPEG
Categoria #
all - tutte 117.053
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 117.053
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022873 0 10 17 208 13 9 46 150 86 94 219 21
2022/20231.898 477 73 259 111 103 106 19 104 231 253 146 16
2023/20241.461 135 131 269 45 27 102 83 94 32 31 205 307
2024/20252.253 38 0 19 79 23 319 107 109 290 690 277 302
2025/20267.874 864 1.030 775 1.373 260 201 1.138 417 398 325 266 827
2026/20271.150 805 345 0 0 0 0 0 0 0 0 0 0
Totale 17.961